Don’t miss outtag icon
Get early access to Digital 100 2026, Similarweb’s official ranking of the fastest-growing brandsPre-register now!banner icon
Lasante.net

November 2025

Lasante.net Market Share Analysis for November 2025

pharmacie en ligne française ✅ vente en ligne de médicaments et de produits de parapharmacie. livraison 24/48h. site agréé par le ministère de la santé
Year Founded2012
Employees51 - 200
Annual Revenue$2M - $5M
lasante.net
Lasante.net
Lasante.net (including company regionals)
  • lasante.net
    lasante.net
See more website traffic and engagement information

Lasante.net Revenue up to November 2025 is 2M - 5M

revenue generated by Lasante.net top domains

Lasante.net top domains revenue over 3 years

Revenue for Lasante.net top domains


Total visits to Lasante.net's top domains

Understand Lasante.net market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

Avg. visit duration in Lasante.net's top domains

Analyze Lasante.net engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

Avg. pageviews on Lasante.net's top domains

See how Lasante.net keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.



Top technologies used by Lasante.net

These are the website technologies, by industry, used by Lasante.net top domains

Advertising (51)

Google Adsense

Google Adsense

Conversion & Analytics (6)

Google Analytics

Google Analytics

Payment & Currencies (6)

Cart Functionality

Cart Functionality

eCommerce (4)

Colissimo

Colissimo

More Technologies

9

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.